Drug Topics

NOVEMBER 24, 2022

Take a look back at our most popular COVID-19 coverage for 2022.

201

201

pharmaphorum

NOVEMBER 15, 2022

The post HLTH 2022 – Day 2 appeared first on. A highlight of the afternoon should be hearing from two major healthcare leaders at Amazon: VP of Health Aaron Martin and Chief Medical Officer Nworah Ayogu. Then more pharma voices with panels featuring speakers from Bristol Myers Squibb and AstraZeneca.

119

119

pharmaphorum

OCTOBER 13, 2022

Day 2 coverage: Click here to read Reuters: Pharma 2022 Day 1 overview. Click here or the image below to read Reuters: Pharma 2022 Live coverage. The post Reuters Pharma 2022 – Day 2 coverage appeared first on.

98

98

pharmaphorum

OCTOBER 14, 2022

Day 3 coverage: Click here to read Reuters: Pharma 2022 Day 1 overview. Click here or the image below to read Reuters: Pharma 2022 Day 2 coverage. The post Reuters Pharma 2022 – Day 3 coverage appeared first on.

98

98

pharmaphorum

OCTOBER 20, 2022

When it comes to knowing what’s currently what in digital transformation, be sure to stay tuned and not miss out on coverage of Day Two of Frontiers Health 2022, brought to you LIVE from Milan! The post Frontiers Health 2022 – day 2 appeared first on. Click here or the image below to read Frontiers Health Day 1 coverage.

119

119

pharmaphorum

OCTOBER 31, 2022

Between the 2nd and 4th November, a veritable who’s who of British industry will gather at the Eden Project in Boldeva, Cornwall for Anthropy 2022, the event’s second year. The post Anthropy 2022 appeared first on. Over three days and across 12 stages within multiple biomes, over 130 sessions will take place, including 300 speakers.

98

98

pharmaphorum

OCTOBER 19, 2022

Frontiers Health 2022 in Milan is LIVE! The post Frontiers Health 2022 – day 1 appeared first on. Opening Day One will be Healthware Group’s CEO and founder Roberto Ascione and WTF Health’s founder and host Jessica DaMassa. As the day begins with an energising networking espresso, so shall it close with a ruminating aperitivo.

105

105

Pharmacy Times

DECEMBER 29, 2022

From newsworthy moments to groundbreaking research, these were the most-read articles on Pharmacy Times in 2022.

132

132

European Pharmaceutical Review

JANUARY 17, 2023

The Cell and Gene Therapy (CGT) Catapult has published its ‘ UK Advanced Therapy Medicinal Products (ATMP) Clinical Trials Report 2022 ’. The research observed this cell type took up 58 percent of UK ATMP clinical trials in 2022. . The number of Phase II/III trials increased from three trials in 2021 to seven trials in 2022.

Documentation 102

Documentation 102

Pharmacy Times

DECEMBER 23, 2022

From newsworthy moments to groundbreaking research, these are the most popular articles in the zoster space, published on Pharmacy Times® during 2022.

122

122

STAT

DECEMBER 19, 2023

trillion in federal and state health care expenditures in 2022 — about 41% of the nearly $4.5 American taxpayers footed the bill for at least $1.8 trillion in both public and private health care spending the U.S. recorded last year, according to the annual report released last week by the Centers for Medicare and Medicaid Services.

Insurance 145

Insurance 145

Fierce Healthcare

JUNE 14, 2023

While national health spending growth slowed in 2022, that trend isn't likely to stick around. While national health spending growth slowed in 2022, that trend isn't likely to stick around, actuaries at CMS said Wednesday.

120

120

OctariusRx

DECEMBER 27, 2022

Unbelievably, we are quickly approaching 2023 and it’s time to look back at of the biggest topics of 2022. Below is a summary of the top topics that generated the most questions and interest in 2022. Drugs shortages continued to plague us in 2022. Preview the New Medications of 2022. for Injection. for Injection.

FDA 80

FDA Patient Care Compounding 80

Pharmaceutical Technology

NOVEMBER 2, 2022

Pfizer has reported a 6% decline in revenue to $22.6bn in the third quarter (Q3) of 2022 as against $24bn in the same quarter last year. The reported diluted earnings per share (EPS) for Q3 2022 stood at $1.51, compared to $1.42 The reported diluted earnings per share (EPS) for Q3 2022 stood at $1.51, compared to $1.42

116

116

Drug Store News

MARCH 23, 2023

More than 2 million providers exchanged patient data more than 21 billion times in 2022, according to Surescripts 2022 National Progress Report.

98

98

pharmaphorum

NOVEMBER 2, 2022

Wednesday 2 nd November heralds the start of Anthropy 2022 at The Eden Project. The post Anthropy 2022 – Day One appeared first on.

98

98

Pharmaceutical Technology

FEBRUARY 1, 2023

Pfizer has reported a 30% operational growth in revenues to $100.3bn in full-year 2022 compared with $81.2bn reported last year. In the fourth quarter (Q4) of 2022, they increased 13% operationally to $24.3bn compared to $23.8bn in the same quarter last year. For Q4 2022, the reported diluted EPS stood at $0.87 as against $0.59

104

104

NF2 BioSolutions

SEPTEMBER 21, 2022

Registration for the NF Community Day is now open from Sept 20th 2022! The post NF Community Day 9th Oct 2022 appeared first on NF2 BioSolutions. We have been very busy organising the NF Community Day in Manchester with other NF organisations and in particular NF Patients United. You MUST register & sign up via this link: [link].

125

125

European Pharmaceutical Review

MARCH 27, 2023

percent between 2022 and 2027. The research includes historic market data from 2017 to 2021, using 2022 as the base year. In the report, analysts showed North America was the largest revenue contributor to the global rapid microbiology testing market in 2022, with the US being the leading country. Don Whitley Scientific Ltd.,

Compounding 104

Compounding Vaccines 104

Pharmaceutical Technology

NOVEMBER 11, 2022

AstraZeneca has reported an 11% rise in total revenue to $10.98bn in the third quarter (Q3) 2022 as against $9.87bn in the year-ago quarter. For the quarter ending on 30 September 2022, product sales were reported at $10.59bn from $9.7bn in Q3 last year, indicating a growth of 9%.

FDA 96

FDA 96

Fierce Healthcare

SEPTEMBER 29, 2023

billion from 2021 to 2022, accordin | The latest report of rising discount drug purchases comes amid Congressional scrutiny on how participating hospitals are opting to use their savings. Discounted prescription drugs purchased wholesale under the 340B program grew 22.3%

Hospitals 103

Hospitals 103

Pharmaceutical Technology

MARCH 2, 2023

to €22.23bn in fiscal 2022 against €19.68bn in 2021. in group sales in fiscal 2022. For fiscal 2022, Merck’s EBITDA increased by 9.4% Merck presented strong data in Healthcare from its 2022 pipeline about Phase II trials for xevinapant (head and neck cancer) and evobrutinib (multiple sclerosis). organic rise.

98

98

Pharmaceutical Technology

FEBRUARY 10, 2023

AbbVie has reported full-year 2022 net revenues of $58.054bn, representing a 3.3% on a reported basis in global net revenues to $15.121bn for the fourth quarter (Q4) of 2022. AbbVie chairman and CEO Richard Gonzalez said: “2022 was another highly productive year capping a decade of outstanding performance. on a reported basis.

98

98

Drug Topics

NOVEMBER 25, 2022

Take a look back at our most popular health system coverage for 2022.

112

112

Drug Topics

DECEMBER 28, 2022

Take a look back at our most popular Total Pharmacy coverage for 2022.

98

98

Pharmaceutical Technology

FEBRUARY 3, 2023

Merck (MSD outside North America) has reported a 2% increase in worldwide sales to $13.83bn in the fourth quarter (Q4) of 2022 from $13.52bn in the previous year’s quarter. Merck has reported a 22% increase in worldwide sales for the full-year 2022, to $59.28bn from $48.7bn in the prior-year quarter.

Vaccines 98

Vaccines 98

Drug Topics

DECEMBER 29, 2022

Take a look back at our most popular dermatology coverage for 2022.

98

98

Drug Topics

DECEMBER 22, 2022

Take a look back at our most popular biosimilars coverage for 2022.

98

98

Drug Topics

DECEMBER 20, 2022

Take a look back at our most popular respiratory coverage for 2022.

98

98

Drug Topics

DECEMBER 23, 2022

Take a look back at our most popular conference coverage for 2022.

98

98

pharmaphorum

JANUARY 11, 2022

As the COVID-19 pandemic continues to impact the healthcare landscape, and the digital transformation of the life sciences industry gathers pace, what can we expect to see in 2022? Join us on Friday 21 January at 2.00pm CET to find out how life science companies can stay ahead of the competition in 2022. Fulvio Fortini.

98

98

Drug Topics

DECEMBER 21, 2022

Take a look back at our most popular pediatric coverage for 2022.

98

98

pharmaphorum

JANUARY 5, 2022

billion doses administered globally by 4th January, with 25 different vaccines either approved for use or under emergency use authorisation , 2022 starts on a more sombre note due to the rise of the Omicron variant. New COVID-19 treatments will also be available in 2022, but they are not a panacea. Despite an estimated 9.25

HIV Treatment and Prevention Agents 98

HIV Treatment and Prevention Agents Vaccines FDA 98

STAT

MARCH 16, 2023

fell in 2022, dropping significantly from a six-decade high during the pandemic, new data suggests. In 2022, there were 733 maternal deaths, according to preliminary agency data, though the final number is likely to be higher. NEW YORK — Deaths of pregnant women in the U.S. More than 1,200 U.S.

89

89

DiversifyRx

JANUARY 4, 2023

Last week we shared our Top 2022 Blog Resources To Optimize your PBM Revenue , which covers our third Pharmacy Profit Pillar PBM Optimization. This week we will dive into the most popular blogs from 2022 that focus on independent pharmacy marketing, our fourth Pharmacy Profit Pillar. Pharmacy Marketing Trends in 2022.

Independent Pharmacies 98

Independent Pharmacies 98

OctariusRx

OCTOBER 23, 2023

The most common Joint Commission deficiencies in 2022 included a variety of medication management issues. The post The most common Joint Commission deficiencies in 2022 appeared first on OctariusRX. Does your facility have a plan in place to avoid deficiencies? Contact us for assistance.

86

86

European Pharmaceutical Review

FEBRUARY 20, 2023

According to a new report on UK life sciences recruitment, there were 11,200 new professional scientific vacancies in the industry across England and Wales in 2022. percent March 2022 was identified as the peak month for scientific jobs in the Pharmaceutical sector (586 vacancies, up 6.2 This represented a year-on-year decrease of -7.4

Clinic Management 74

Clinic Management Vaccines 74